Personalis is a rapidly growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. Our ImmunoID NeXT Platform® is enabling the development of next generation immuno-oncology therapeutics and diagnostics. Located in Menlo Park, CA we are seeking a talented and highly motivated Regional Directors of Medical Affairs to join our team, working remotely.  

Summary: 

The successful candidate will be responsible for regional strategic KOL development and study execution to support the overarching clinical diagnostic strategy for the medical affairs team, reporting to the Senior Director, Scientific and Medical Affairs.  As part of this role the candidate will work closely and collaboratively with the commercial sales/marketing teams as well as the Clinical development and business development teams.  

Responsibilities:

  • Develop, execute, and maintain a strong regional key opinion leader program that supports the overall clinical strategy.  Preference will be given to candidates that have established a network of KOLs at NCI centers in the top cancers, including breast, NSCLC, GI, GU
  • Support of CDLs in the field to drive awareness and adoption of Dx products
  • Support commercial efforts regionally with high level clinical presentations at advisory boards, tumor boards, State oncology societies, community-based oncology practices, nursing societies/programs etc.
  • Attend relevant local, US or international scientific meetings to support the clinical strategy of the company and other members of the Personalis team, including the commercial team and the pharma business development team
  • Regionally initiate, drive, and support clinical studies/trials tied to clinical Dx strategy
  • Contribute to the generation of abstracts, publications and detailed reporting and intelligence at key national and local science meetings for competitive intelligence tracking 
  • Contribute to VOC for new product development
  • Facilitate and implement the clinical strategies of the company by identifying regional KOLs to support retrospective studies or prospective clinical trials to build on the clinical utility of Personalis products for payer initiatives as well as NCCN guidelines
  • Maintain clinical, scientific, and technical expertise in specific therapeutic areas by reviewing the current literature and attending key scientific and technical meetings\
  • Participate in the training and education of internal stakeholders (Commercial diagnostics team, Pharma business development) and external stakeholders (Physician speaker programs, advisory boards)
  • Participation in molecular tumor boards as necessary to support the interpretation of NeXT Dx clinical reporting
  • Initial position will be an individual contributor, however, as the diagnostic initiatives grow within company, preference will be for candidates with prior leadership experience with managing a team of MSLs

Requirements:

  • MD, MD/PhD, or PhD with both deep clinical and translational NGS biomarker experience in oncology within the pharmaceutical/biotechnology/diagnostic biomarker industry.  Preference will be given to Board certified medical oncologists as well as MD, MD/PhDs with extensive molecular NGS biomarker experience
  • 5-7 years’ experience as a Medical Science Liaison or regional director of medical affairs with experience in solid tumor oncology.  Preference given to those with both heme and solid tumor oncology experience
  • Prefer candidates with deep translational biomarker experience as well as clinical trial/clinical research experience in oncology, with emphasis in molecular genetics/NGS and immuno-oncology
  • Experience working with regional cooperative groups as well as advocacy groups to drive clinical strategy
  • Excellent oral, written, and presentation skills to include medical writing/communication/slide deck generation, manuscript preparation and writing clinical protocols
  • Demonstrated experience in presenting technical and clinical content to various HCPs including surgeons, oncologists, pathologists in NCI comprehensive cancer centers, cooperative groups, scientific meetings, and community practices
  • Demonstrated experience in presenting technical and clinical content to various stakeholders in Pharmaceutical/biotech/diagnostics
  • Track record of first and/or senior author peer reviewed manuscripts in oncology
  • Solid computer skills including Microsoft word, PowerPoint and Excel and experience working with CRMs such as salesforce
  • Ability to travel extensively within region ~30-50%, with occasional non-region travel for key scientific meetings
  • Ability to work well under pressure and tight timelines

 

Personalis is an Equal Opportunity Employer/Minorities/Females/Veterans/Disabilities.  Personalis offers a competitive compensation package. 

 

#LI-LK1

 

 

Apply for this Job

* Required

  
  
When autocomplete results are available use up and down arrows to review
+ Add Another Education


U.S. Equal Opportunity Employment Information (Completion is voluntary)

Individuals seeking employment at Personalis, Inc are considered without regards to race, color, religion, national origin, age, sex, marital status, ancestry, physical or mental disability, veteran status, gender identity, or sexual orientation. You are being given the opportunity to provide the following information in order to help us comply with federal and state Equal Employment Opportunity/Affirmative Action record keeping, reporting, and other legal requirements.

Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.


Form CC-305

OMB Control Number 1250-0005

Expires 05/31/2023

Voluntary Self-Identification of Disability

Why are you being asked to complete this form?

We are a federal contractor or subcontractor required by law to provide equal employment opportunity to qualified people with disabilities. We are also required to measure our progress toward having at least 7% of our workforce be individuals with disabilities. To do this, we must ask applicants and employees if they have a disability or have ever had a disability. Because a person may become disabled at any time, we ask all of our employees to update their information at least every five years.

Identifying yourself as an individual with a disability is voluntary, and we hope that you will choose to do so. Your answer will be maintained confidentially and not be seen by selecting officials or anyone else involved in making personnel decisions. Completing the form will not negatively impact you in any way, regardless of whether you have self-identified in the past. For more information about this form or the equal employment obligations of federal contractors under Section 503 of the Rehabilitation Act, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp.

How do you know if you have a disability?

You are considered to have a disability if you have a physical or mental impairment or medical condition that substantially limits a major life activity, or if you have a history or record of such an impairment or medical condition.

Disabilities include, but are not limited to:

  • Autism
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, or HIV/AIDS
  • Blind or low vision
  • Cancer
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or hard of hearing
  • Depression or anxiety
  • Diabetes
  • Epilepsy
  • Gastrointestinal disorders, for example, Crohn's Disease, or irritable bowel syndrome
  • Intellectual disability
  • Missing limbs or partially missing limbs
  • Nervous system condition for example, migraine headaches, Parkinson’s disease, or Multiple sclerosis (MS)
  • Psychiatric condition, for example, bipolar disorder, schizophrenia, PTSD, or major depression

1Section 503 of the Rehabilitation Act of 1973, as amended. For more information about this form or the equal employment obligations of Federal contractors, visit the U.S. Department of Labor's Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp.

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.